5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity.
参考文献:
1. Philip Jones, et al. Salts of heterocyclic modulators of hif activity for treatment of disease. EP3110420B1